BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,008,029 | -44.1% | 79,704 | -32.5% | 0.03% | -60.0% |
| Q2 2023 | $5,380,636 | +45.9% | 118,100 | +29.9% | 0.08% | +8.1% |
| Q1 2023 | $3,687,391 | +322.7% | 90,912 | +431.2% | 0.07% | +184.6% |
| Q4 2022 | $872,403 | -9.1% | 17,116 | -3.9% | 0.03% | -10.3% |
| Q3 2022 | $960,000 | +231.0% | 17,818 | +294.8% | 0.03% | +190.0% |
| Q2 2022 | $290,000 | +13.3% | 4,513 | +36.8% | 0.01% | +11.1% |
| Q1 2022 | $256,000 | -58.8% | 3,300 | -54.4% | 0.01% | -66.7% |
| Q4 2021 | $621,000 | +54.9% | 7,236 | +45.3% | 0.03% | +125.0% |
| Q2 2021 | $401,000 | +100.5% | 4,980 | +109.6% | 0.01% | +9.1% |
| Q1 2021 | $200,000 | -68.8% | 2,376 | -70.2% | 0.01% | -26.7% |
| Q4 2020 | $641,000 | +36.1% | 7,986 | +36.5% | 0.02% | +50.0% |
| Q3 2020 | $471,000 | -82.5% | 5,852 | -81.2% | 0.01% | -83.3% |
| Q2 2020 | $2,687,000 | +122.1% | 31,200 | +109.4% | 0.06% | +122.2% |
| Q1 2020 | $1,210,000 | -85.6% | 14,900 | -85.2% | 0.03% | -52.6% |
| Q4 2019 | $8,430,000 | +3.0% | 100,812 | +0.9% | 0.06% | -33.7% |
| Q2 2019 | $8,181,000 | +449.8% | 99,900 | +445.9% | 0.09% | +561.5% |
| Q1 2019 | $1,488,000 | +20.3% | 18,300 | -2.7% | 0.01% | -13.3% |
| Q4 2018 | $1,237,000 | -88.5% | 18,800 | -86.6% | 0.02% | -78.6% |
| Q3 2018 | $10,777,000 | +7.2% | 139,800 | +2.6% | 0.07% | +37.3% |
| Q2 2018 | $10,057,000 | -15.8% | 136,200 | -25.8% | 0.05% | -23.9% |
| Q1 2018 | $11,942,000 | +2723.2% | 183,600 | +2703.9% | 0.07% | +509.1% |
| Q4 2017 | $423,000 | +80.8% | 6,548 | +75.5% | 0.01% | -47.6% |
| Q3 2017 | $234,000 | -37.8% | 3,732 | -48.6% | 0.02% | -71.6% |
| Q1 2017 | $376,000 | -62.5% | 7,255 | -67.9% | 0.07% | -77.9% |
| Q4 2016 | $1,002,000 | +148.6% | 22,605 | +167.0% | 0.34% | +144.5% |
| Q3 2016 | $403,000 | +96.6% | 8,466 | +69.5% | 0.14% | -48.1% |
| Q1 2016 | $205,000 | – | 4,994 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |